← The Wire
VCRE
Vicore Pharma Holding AB
Pharmaceutical Preparations · V7 · CIK 2124403
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan…
$3.29B
Market cap
$11.70
Last close
-5.5%
1D
-15.9%
5D
8K
Volume
Price$11.70-28.0%· 1M
Volume
Jul 6L $11.70 · H $16.25Jul 16
Fundamentals & quality
Fundamentals not yet available for this company.
Similar companies
Comparable business profile · signals at a glance